The understanding of the pathophysiology of atherosclerosis and related vascular diseases has changed over the last decade, providing new perspectives for preventive and therapeutic strategies.

Cardiovascular diseases (CVDs) continue to dominate global mortality statistics, with immune dysregulation emerging as a central feature in their ...

Dr Ray O’Connor takes a look at the latest clinical articles on rheumatoid arthritis – and how its management has been so ...

ABSTRACT: Introduction: In diabetics, hyperglycemia leads to dyslipidemia and liver damage. Integrative therapy combining traditional medicine with a conventional antidiabetic drug is an innovative ...

Cholesterol crystal embolism can be a life-threatening complication of advanced atherosclerosis. Pathophysiology and molecular targets for treatment are largely unknown. We aimed to develop a new ...

Cardiovascular diseases (CVDs) continue to dominate global mortality statistics, with immune dysregulation emerging as a ...

The field of coronary artery disease (CAD) has long been thirsty for biomarkers that do not just echo the standard modifiable risk factors—such as cholesterol and blood pressure—but offer fresh clues ...

In the following two articles, the pathophysiology, medical management, and nursing care of patients are discussed. An in-depth model care plan illustrates the complexity of the disease and its ...

The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression of atherosclerosis in patients with coronary ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal. The Danish ...

During atherosclerosis, lipid-rich plaques are formed in large- and medium-sized arteries, which can reduce blood flow to tissues. This situation becomes particularly precarious when a plaque develops ...

Correspondence to Professor Ju Han, Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250014, China; hanjujack{at}163.com Background The optimal treatment ...